We intended to determine how the liver copes with the massive handling of lipids induced by OE (oleoyl-oestrone), as well as to characterize and differentiate the actual OE effects from those that may be only the consequence of decreased food intake. Thus we used male rats treated with oral OE (10 nmol/g per day) compared with a vehicle only PF (pair-fed) group and controls fed ad libitum (vehicle only). Plasma parameters, and total liver lipids, glycogen, DNA and total mRNA were measured. RNA was extracted and used for real-time PCR analysis of the gene expression of enzymes and regulatory factors of liver energy metabolism. Most hepatic proteins showed similar gene expressions in OE and controls, but the differences widened between OE and PF rats, showing that OE effects could not be merely attributed to a lower energy intake. The liver of OE-treated rats largely maintained its ability to mobilize glucose for the synthesis of fats; this was achieved in part by a peculiar combination of regulative modifications that facilitate both fatty acid disposal and restrained glucose utilization under conditions of limited food supply but ample availability of internal energy stores. In conclusion, the results presented suggest that the effect of OE on liver metabolism may be (at least in part) mediated through an insulin-sensitivity-dependent modulation of the expression of SREBP-1c (sterolregulatory-element-binding protein-1c), resulting in the unique combined effect of mildly increased (or maintained) glucose disposal but also limited enhancement of lipogenesis.
INTRODUCTION
OE (oleoyl-oestrone) is a signal of adipose tissue carried in the plasma by lipoproteins [1] that elicits marked (and dosedependent) decreases in body fat [2, 3] , in part through actions on WAT (white adipose tissue), such as the massive loss of lipid, decreased cell size and increased apoptosis [4, 5] . Other actions are central, such as the decrease in food intake [2] and the maintenance of energy expenditure [6] in spite of massive energy losses [3, 7] , nevertheless sparing body protein [3] .
Under conditions of low energy intake (resulting in decreased glucose availability and enhanced lipolysis), OE maintains glycaemia, and liver glycogen stores [8, 9] , but lowers insulinaemia, and overall glucose utilization [10] . These combined effects suggest that no additional liver glucose output is needed, since the flow of food-derived glucose is enough to maintain glucose homoeostasis.
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The fatty acids freed by WAT lipolysis are largely used by peripheral tissues as the main energy substrate [3, 4, 7] . The OEinduced shift in the distribution of tissue lipoprotein lipase activity favours the use of fats by the muscle, and decreases its liver and WAT storage in obese rats [11] . This situation contrasts sharply with the metabolic environment caused by a simple decrease in food intake, when lowered glucose levels are largely maintained by increased liver glucose output [12] . Low glucose also results in increased lipolysis and synthesis of ketone bodies [13] . These effects are the consequence of energy saving [14] , resulting in decreased thermogenesis [15] and overall energy expenditure [16] .
The regulation of hepatic metabolism plays a key role in the overall energy balance, since the liver is the major site of carbohydrate metabolism and lipogenesis. The synthesis of most glycolytic and lipogenic enzymes is eventually regulated by dietary status and nutrient (e.g. glucose) levels [17] . The latter response takes place largely at the transcriptional level, modulating the expression of genes encoding glycolytic and lipogenic enzymes [18] .
Since the liver is a key organ for body energy management, we centred our study on the analysis of the gene expressions of key enzymes and regulatory factors in response to the challenges of OE treatment or relative food deprivation (pair-feeding). We intended to better understand the ease with which OE facilitates the use of internal energy stores and to obtain information on the regulatory mechanisms modulated by OE in liver.
MATERIALS AND METHODS

Animals and sample preparation
Adult male Wistar rats, kept under standard conditions of housing and feeding, were made overweight by a limited period of cafeteria diet feeding, as previously described [19] . The rats weighed 355 + − 5 g when the experiment began; three groups, of eight rats each, were randomly selected: controls, OE and PF (pair-fed). All animals received every day an oral gavage of 0.2 ml of sunflower oil (7 kJ), which was supplemented in the OE group with 10 nmol/g OE (OED, Barcelona, Spain). Controls and OE had free access to pellet food (maintenance chow; Panlab, Barcelona, Spain); and the PF were allowed to eat every day only the amount of food consumed by the OE group; all rats had water available ad libitum. PF rats completely ate the food allotted each day. On day 10, the rats were killed by decapitation and blood was recovered in plastic beakers; serum was separated and frozen for later analysis. The liver was rapidly excised, weighed, sampled, frozen and kept at -80
• C until processed. The animals were kept, handled and killed following the procedures approved by the University of Barcelona Animal Welfare and Ethics Committee, in full agreement with the norms and procedures set forth by the European Union and the Governments of Catalonia and Spain.
Analytical procedures
Serum was used to measure glucose (Trinder glucose kit; Sigma, St. Louis, MO, U.S. A.) , triacylglycerols (kit 11528; Biosystems, Barcelona, Spain), non-esterified fatty acids (kit NEFA-C; Wako, Richmond, VA, U.S. A.) and insulin (rat insulin RIA kit; Linco, St. Louis, MO, U.S. A.) . Liver samples were used for glycogen determination as glycosyl residues [20] . Lipid content of liver samples were extracted with trichloromethane/methanol (2:1), dried and weighed [21] .
Total DNA liver was measured using a standard fluorimetric method with 3,5-diaminobenzoic acid (Sigma) and bovine DNA (Sigma) as the standard [22] . Tissue DNA content allowed the calculation of the number of cells per g of tissue and in the whole liver, based on the assumption that the DNA content per cell is constant in mammals; here we used the genomic DNA size data [23] for somatic rat cells (5.60 pg per cell). Mean cell volume was estimated from the number of cells and the volume of the organ, calculated using a liver density of 1.10 g/ml [24] .
Real-time PCR expression analysis
Total tissue RNA was extracted using the Tripure reagent (Roche Applied Science, Indianapolis, IN, U.S. A.) and quantified with an ND-100 spectrophotometer (Nanodrop Technologies, Wilmington, DE, U.S.A.). Tissue total mRNA was determined by using the poly-(A) mRNA detection system kit (Promega, Madison, WI, U.S. A.) .
RNA samples were reverse transcribed using the MMLV (Moloney-murine-leukaemia virus) reverse transcriptase (Promega) and oligo-dT primers. Real-time PCR amplification was carried out using 10 μl amplification mixtures containing Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, U.S.A.), equivalent to 8 ng of reverse-transcribed RNA and 300 nM primers. Reactions were run on an ABI PRISM 7900 HT detection system (Applied Biosystems). The list of genes and primes used is given in Supplementary Table S1 (http://www.bioscirep.org/bsr/030/bsr0300081add.htm). A semiquantitative approach for the ultimate estimation of the number of copies of each expressed gene mRNAs was used as previously described [25] . Cyclophilin was used as charge control gene in all samples.
Preparation of crude membrane fraction, nuclear extracts and Western-blot analysis
Liver samples were homogenized in a buffer containing 10 mM Tris/HCl, 10 mM NaCl, 3 mM MgCl 2 , 0.5 % Triton X-100, 1 mM PMSF, 1 mM Na 3 VO 4 (sodium orthovanadate) and Complete TM protease inhibitor cocktail (Sigma). Nuclei were pelleted with a 10 min centrifugation (at 500 g) at 4
• C and washed once with the same buffer. The nuclear pellet was resuspended and kept for 30 min at 4
• C in a hypertonic buffer: 10 mM Hepes (pH 7.4) containing 0.42 M NaCl, 1.5 mM MgCl 2 , 2% glycerol, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF, 1 mM sodium orthovanadate and Complete TM protease inhibitor cocktail (Sigma). A clear nuclear extract was obtained by 30 min centrifugation (100 000 g) at 4
• C. The supernatant from initial low-speed centrifugation was further spun at 100 000 g for 30 min at 4
• C to obtain a pellet of the crude membrane fraction. The membrane pellet was resuspended in 10 mM Tris/HCl (pH 6.8) containing 10 mM NaCl, 1 % SDS, 1 mM EDTA and 1 mM EGTA.
Proteins from the membrane fraction and nuclear extracts (50 μg) were separated by SDS/PAGE in a 7.5 % gel and electrotransferred on to a PVDF membrane (Millipore, Billerica, MA, U.S. A.) . Membranes were incubated with a mouse monoclonal antibody for SREBP-1c (sterol-regulatoryelement-binding protein-1c) (2A4), lamin B1(2L-5) (Santa Cruz Biotechnology, Santa Cruz, CA, U.S. A.) 
Statistical analysis
Statistical analysis was carried out using the Prism 4 program (GraphPad Software, San Diego, CA, U.S. A.) . Differences between groups were established by using a one-way ANOVA. A Tukey's multiple comparison test was performed for the evaluation of significant differences between groups. Differences were assumed to be significant when P < 0.05.
RESULTS
Body weight and plasma parameters
After 10 days of treatment, the body weight of control rats increased by 2.6 + − 0.4 %; PF lost 8.5 + − 0.8 % and OE rats lost 9.9 + − 0.8 %. Mean food intake of controls was 18.0 + − 0.2 g/day and that of OE (and thus PF) was 10.4 + − 0.3 g, representing a mean 58 + − 2 % of the food (energy) ingested by controls. Plasma parameters are shown in Table 1 . In OE rats, plasma glucose and insulin were lower than in controls, but in the PF rats the levels were even lower. The decrease in triacylglycerols and the increase in non-esterified fatty acids observed in PF versus controls were consistent with food restriction, but the OE group showed a significant decrease in plasma non-esterified fatty acids with respect to controls and PF groups. Table 2 shows the liver weight, DNA and RNA contents of control, PF and OE-treated rats. Pair-feeding resulted in the loss of liver weight (down by approx. 35 %), but not of liver cells. Neither liver weight nor its cellularity was significantly affected by OE. As a consequence, the liver cells of PF rats were smaller than those of controls or OE. Total RNA content was, again, lower in PF compared with controls; with OE being not different from controls. However, OE-treated rat liver contained approx. 53 % of the mRNA controls; the figure for PF was even lower, in the range of 28 %. When correcting these values by the number of cells, we found that cells from OE-treated rats contained 58 % of the mRNA of controls, and PF animals only 22 %. Table 3 shows the exhaustion of glycogen reserves in PF but its remaining constant in OE-treated rats. Total liver lipids tended to be lower in PF rats and remained constant in OE. Pair-feeding resulted in a generalized decrease in the gene expression of most enzymes: glucokinase, glycogen phosphorylase, phospho-fructokinase, glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase, pyruvate carboxylase, pyruvate dehydrogenase kinases 2 and 4 and glucose-6-phosphate dehydrogenase. The only increases in gene expression were those of PEPCK (phosphoenolpyruvate carboxykinase) and glucose-6-phosphatase. The pattern shown by OE rats was much closer to controls and markedly different from PF. The only genes decreasing their expressions were PEPCK and pyruvate carboxylase. All other gene expressions were similar to those of controls except for actual increases in glucokinase, phospho-fructokinase, pyruvate dehydrogenase kinase 4, glucose-6-phosphate dehydrogenase and the malic enzyme.
Liver cellularity and composition
Gene expression of energy metabolism enzymes and regulating factors
The expression of genes codifying enzymes of lipid metabolism are presented in Figure 2 ; Supplementary Table S3 (http://www.bioscirep.org/bsr/030/bsr0300081add.htm) shows these expressions in absolute values. Again, the PF group showed a generalized decrease in gene expression, affecting hepatic lipase, adiponutrin, citrate:ATP lyase, acetyl-CoA carboxylases 1 and 2, fatty acid synthase, steroyl-CoA desaturase 1 and glycerol-3-phosphate acyl-transferase. There were increases only in fatty acid transport protein 2, hormone-sensitive lipase and carnitine palmitoleoyl-transferase expressions. The pattern for OE rats was very different, with a marked increase in gene expression of fatty acid translocase, and a less marked (albeit significant) increase in fatty acid transport protein 2, hormone-sensitive lipase, carnitine palmitoleoyl-transferase, acyl-CoA dehydrogenase (long chain), steroyl-CoA desaturase, glycerol-3-phosphate acyl-transferase and long-chain acyl-CoA synthetase compared with controls. Figure 3 shows the expression of the genes for a number of energy metabolism regulating factors (the absolute values are given in Supplementary Table S4 at http://www.bioscirep. org/bsr/029/bsr0290000add.htm). Pair-feeding decreased the gene expression of most of the factors studied, in particular glucose-related [ChREBP (carbohydrate-responsive elementbinding protein) and LXR (liver X receptor)] and insulin-related (insulin receptor and SREBP-1c) regulatory genes. This pattern, along with an increase in PPARα (peroxisome-proliferatoractivated receptor α) and a marked decrease in PPARβ/δ gene expression, was indicative of an adaptation to low levels of intake. OE treatment induced fewer changes with respect to controls, the only difference being a marked increase in the expression of SREBP-1c. Figure 4 shows the protein levels of both precursor and nuclear SREBP-1c in membrane and nuclear extracts of liver. In PF rats, both forms decreased when compared with controls; however, in the OE group precursor and nuclear protein levels were increased compared with controls, in parallel with SREBP-1c gene expression.
SREBP-1c protein levels
DISCUSSION
Simple food restriction induces the loss of liver energy: i.e. glycogen, lipid and protein content [26] , which result in smaller PF cell size but not in the loss of cells. PF rat cells lost a large share of their total RNA, with mRNA being only a fraction of its proportion in controls. OE treatment also reduced liver mRNA levels, which suggests a generalized decrease in liver protein synthesis. This is an important point, since the reduction of total mRNAs to approximately half the mRNA of controls represents an overall trend in the same line but less marked in OE than that observed in PF rats. The uniformity in the measurement of expression between controls and OE represents a relative increase in the given protein expression with respect to the whole mRNA pool. As a consequence, the apparent lack of change in most of the pathways investigated suggests that there is a metabolic effort to maintain these pathways close to controls' activity at the expense of the synthesis of other proteins. Figure 5 presents a comparative scheme of the main liver energy metabolism pathways. The genes for the main paths controlling enzymes have been represented in parallel for PF and OE as a way to compare the differential effects on liver metabolism of dietary restriction and OE.
In PF rats, there was a generalized decrease in the gene expression of most enzymes, but there was a fair relationship between the gene expression data and the metabolic changes observed. Thus lipogenesis enzyme gene expressions were decreased in PF rats. The only gene-expression increases in lipid metabolism were related to enhanced lipid utilization: increased uptake of non-esterified fatty acids (fatty acid transport protein), which agrees with higher plasma levels, hydrolysis of triacylglycerols (hormone-sensitive lipase), and transference of fatty acids into the mitochondria (carnitine palmitoleoyl-transferase), all consistent with a lower liver lipid content. Glycolytic enzyme gene expressions were also decreased, but those related to gluconeogenesis (PEPCK and glucose-6-phosphatase) were increased. This profile is coherent with the exhausted liver glycogen stores. The decrease in pyruvate dehydrogenase kinases' gene expressions suggests that pyruvate dehydrogenase activity may also be increased, thus providing extra acetyl-CoA for the tricarboxylic acid cycle operation under conditions of limited energy supply.
In contrast, OE showed only limited differences compared with controls. Liver glucose utilization was probably increased by OE treatment, since both pentose-phosphate and glycolytic pathway enzyme gene expressions were increased. The parallel inhibition of the gluconeogenic enzyme PEPCK seems to indicate that glycolysis may be favoured over gluconeogenesis. In OE-treated rats, glucose utilization in peripheral tissues is decreased [10] , and there is plenty of glucose available the liver, since glycogen stores are essentially maintained with respect to controls [8, 9] . Consequently, it may be inferred that high glucose availability may facilitate that part of this glucose be derived to synthetic processes. In addition, the parallel increases in glucose-6-phosphate dehydrogenase and malic enzyme gene expressions hint at an increased availability of NADPH for biosynthesis. The uptake of non-esterified fatty acids may be enhanced, as suggested by the increased expression of fatty acid transport protein 2, and especially that of fatty acid translocase. There were no differences between OE and controls in the expression of acetyl-CoA carboxylase and fatty acid synthase, which suggest that de novo synthesis from glucose was unchanged. These results suggest that at least part of the fatty acids taken up from the bloodstream may be further unsaturated and re-esterified (increased steroylCoA desaturase and glycerol-3-phosphate acyl-transferase gene expressions) to render triacylglycerols, exported in lipoproteins. It may be further speculated that these processes are helped by the abundance of NADPH used to generate glycerol phosphate or sustain fatty acid unsaturation [27] . However, the increased expression of carnitine palmitoleoyl-transferase points to a higher availability of fatty acids for mitochondrial oxidation, as suggested by the increased long-chain acyl-CoA dehydrogenase gene expression.
PPARs are important effectors regulating lipid metabolism [28] ; PPARα is expressed mainly in the liver where it up-regulates genes involved in lipid oxidation in the fasted state [29] . This is in agreement with the increased expression of PPARα in PF rats. In the liver, PPARβ/δ-specific agonists suppress hepatic glucose output, promote glucose flux through the pentose phosphate shunt and stimulate fatty acid synthesis [30] . The marked decrease in PPARβ/δ expression in the PF group is, again, consistent with a situation of limited glucose availability. In contrast, in OE rats, the expression of PPARβ/δ was not inhibited, which can be related to higher activity of the pentose phosphate shunt, and the preservation of glycogen stores. In addition, PPARβ/δ increases the expression of liver fatty acid translocase [31] , as found in the OE group. The decreased insulin pathway signalling activity in PF is consistent with low plasma levels of insulin and glucose, and the increased liver glucose output typical of a low energy availability situation. However, OE treatment did not change (compared with controls) the insulin receptor gene expression. OE-treated rats maintain quite normal blood glucose, with a marked decrease in insulin levels [3, 8] . Insulin-mediated repression of gluconeogenesis involves the inhibition of PEPCK transcription [32] , as found in OE rats in spite of lower insulin levels, which points to an increase in liver insulin-sensitivity.
SREBP-1c activity is primarily regulated by insulin, which activates its expression and proteolytic cleavage, increasing the nuclear active form [33, 34] . SREBP-1c enhances the transcription of genes favouring the catabolism of glucose and lipogenesis [27, 33] . ChREBP is primarily regulated by pentose phosphate pathway products, generated under conditions of high glucose availability [35] . In PF animals, as expected, gene expressions of both SREBP-1c and ChREBP were decreased, as were those of the enzymes they regulated, resulting in lower glucose utilization and lipogenesis. The situation contrasts with that of OE rats where the expression of SREBP-1c was increased, but that of ChREBP remained unchanged. As a consequence, the gene expressions of the enzymes controlled more markedly by ChREBP (pyruvate kinase, acetyl-CoA carboxylase and fatty acid synthase) [27, 35] remained unchanged. However, all those regulated more specifically by SREBP-1c (acyl-CoA desaturase, glycerol-3-phosphate-acyl-transferase, glucose-6-phosphate dehydrogenase and the malic enzyme) [18] increased their gene expressions. Since OE rats showed low insulinaemia, normoglycaemia and a postulated higher liver insulin-sensitivity, the control of lipogenesis and glycolysis became partially distorted: the lack of changes in glucose resulted in unchanged ChREBP, whereas increased insulin-sensitivity resulted in an enhanced SREBP-1c response. This pattern is summarized in Supplementary Figure  S1 (http://www.bioscirep.org/bsr/030/bsr0300081add.htm).
LXR transcription factors are also involved in the regulation of liver energy and cholesterol metabolism [27] . LXR increases the mRNA levels of SREBP-1c but has little effect inducing its activation to the nuclear form [34] . Recent studies have shown that glucose also regulates LXR [36] . OE maintained unchanged LXR gene expression, in contrast with PF rats' decrease; thus it may be related to sustained glucose availability. The increase in the active nuclear form of SREBP-1c of OE rats gives support to the critical role of insulin in its activation [34] and helps explain ours results.
In conclusion, the results presented suggest that the effect of OE on liver metabolism may be (at least in part) mediated through an insulin-sensitivity-dependent modulation of the expression of SREBP-1c, resulting in the unique combined effect of mildly increased (or maintained) glucose disposal but also limited enhancement of lipogenesis. Other transcription factors such as PPARβ/δ, LXR and ChREBP may play complementary functions in the regulation of liver energy metabolism under OE treatment. In addition we showed that the slimming effect of OE treatment could not be explained exclusively on the basis of the simple decrease in food intake. The downward arrow indicates significantly decreased expression compared with controls; double-headed arrow indicates absence of significantly different expression compared with controls; upward arrow indicates significantly increased expression compared with controls. GK, glucokinase; G6PDH, glucose-6-dehydrogenase; PEP , phosphoenolpyruvate; pyrK, pyruvate kinase; pyrDH, pyruvate dehydrogenase; AcCAC, acetyl-CoA carboxylase; FAS, fatty acid synthase; desaturase, palmitoleoyl-CoA desaturase; uns-acyl-CoA, unsaturated acyl-CoA; G3PAT, glycerol-3-phosphate acyl-transferase; G6Pase, glucose 6-phosphatase. 
